Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity
- 21 June 2002
- journal article
- fj express-summarie
- Published by Wiley in The FASEB Journal
- Vol. 16 (10), 1301-1303
- https://doi.org/10.1096/fj.01-1012fje
Abstract
Most of the 400 million grass pollen-allergic patients worldwide are co-sensitized to several unrelated grass pollen allergens. Based on frequent co-sensitization patterns determined in 200 grass pollen-allergic patients, three recombinant hybrid molecules were developed by polymerase chain reaction-based mending of cDNAs coding for the major timothy grass pollen allergens (Phl p 1, Phl p 2, Phl p 5, Phl p 6) for vaccination against grass pollen allergy. The hybrids rP2-P6, rP6-P2, and rP5-P1 contained most of the epitopes of natural grass pollen extract and induced stronger lymphoproliferative responses in cultured mononuclear cells of grass pollen-allergic patients than did equimolar mixtures of the individual allergens. Immunization of mice with the hybrids yielded higher antibody titers than did immunization with the individual allergen components or grass pollen extract, which suggests that the individual components of the hybrids can serve as molecular scaffolds for each other to enhance their immunogenicity. Antibodies induced with the hybrids in mice inhibited the binding of grass pollen-allergic patients' immunoglobulin E to each of the individual allergens and grass pollen extract and may thus represent protective antibodies. The principle of increasing the immunogenicity of antigens by engineering hybrids thereof may be applied not only for the treatment of polysensitized allergic patients but also for general vaccine development.Keywords
Funding Information
- Austrian Science Fund (Y078GEN, F01805, F01807)
- Österreichischen Akademie der Wissenschaften
This publication has 40 references indexed in Scilit:
- Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: Different allergenicity of Bet v 1 and Bet v 2Journal of Allergy and Clinical Immunology, 1996
- Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populationsJournal of Allergy and Clinical Immunology, 1996
- Grass pollen immunotherapy induces highly cross-reactive IgG antibodies to group V allergen from different grass speciesAllergy, 1995
- Complementary DNA cloning of the major allergenPhl p I from timothy grass (Phleum pratense); recombinantPhl p I inhibits IgE binding to group I allergens from eight different grass speciesJournal of Allergy and Clinical Immunology, 1994
- Immunodominance of a recombinant T-cell epitope depends on its molecular environmentMolecular Immunology, 1993
- Molecular characterization of Phl p II, a major timothy grass (Phleum pratense) pollen allergenFEBS Letters, 1993
- Antigen-Specific Suppressor Factors of Noncytotoxic CD8+ Suppressor T Cells Downregulate Antibody Responses Also to Unrelated Antigens When the Latter Are Presented as Covalently Linked Adducts with the Specific AntigenCellular Immunology, 1993
- Properties of Tree and Grass Pollen Allergens: Reinvestigation of the Linkage between Solubility and AllergenicityInternational Archives of Allergy and Immunology, 1993
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976